# Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-07-07

Status: RECRUITING · Sponsor: Genmab · Condition: Non-small Cell Lung Cancer (NSCLC)

- Company: Genmab
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07288177

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.